Key regions: Canada, United States, France, Europe, United Kingdom
The Skin Treatment (Pharmacies) market in worldwide is experiencing steady growth due to changing customer preferences and the influence of local special circumstances.
Customer preferences: Customers in the Skin Treatment (Pharmacies) market are increasingly seeking products that address specific skin concerns such as acne, aging, and hyperpigmentation. This shift in preferences can be attributed to the growing awareness about skincare and the desire for personalized solutions. Customers are also looking for products that are natural, organic, and free from harmful chemicals, reflecting a broader trend towards clean and sustainable beauty. In addition, the convenience of purchasing skincare products from pharmacies, which often offer a wide range of brands and professional advice, is appealing to customers.
Trends in the market: One of the key trends in the Skin Treatment (Pharmacies) market is the rising demand for anti-aging products. As the global population ages, there is a growing need for skincare solutions that target wrinkles, fine lines, and sagging skin. This trend is particularly prominent in developed countries where the aging population is significant. In emerging markets, on the other hand, there is a rising demand for skincare products that address specific skin concerns such as acne and hyperpigmentation. This can be attributed to factors such as changing lifestyles, pollution, and urbanization. Another trend in the market is the increasing popularity of natural and organic skincare products. Consumers are becoming more conscious about the ingredients used in skincare products and are actively seeking out products that are free from harmful chemicals. This trend is driven by factors such as growing health and wellness awareness, concerns about environmental sustainability, and the desire for clean beauty. Pharmacies are well-positioned to cater to this trend by offering a range of natural and organic skincare brands.
Local special circumstances: The Skin Treatment (Pharmacies) market is influenced by local special circumstances in different regions. In developed countries, the market is driven by factors such as high disposable incomes, advanced healthcare infrastructure, and a strong emphasis on personal grooming. These countries also have a well-established network of pharmacies that offer a wide range of skincare products, making them easily accessible to consumers. In emerging markets, the market is influenced by factors such as rapid urbanization, changing lifestyles, and increasing awareness about skincare. Pharmacies play a crucial role in these markets by providing consumers with access to affordable skincare products and professional advice. However, challenges such as limited access to healthcare and lower disposable incomes can impact the growth of the market in these regions.
Underlying macroeconomic factors: The growth of the Skin Treatment (Pharmacies) market is also influenced by underlying macroeconomic factors. Factors such as GDP growth, disposable incomes, and consumer spending patterns play a significant role in shaping the market dynamics. In developed countries, where disposable incomes are higher, consumers are more willing to spend on premium skincare products. In emerging markets, on the other hand, affordability is a key consideration, and consumers tend to opt for more affordable skincare options. In conclusion, the Skin Treatment (Pharmacies) market in worldwide is witnessing growth due to changing customer preferences, including the demand for personalized and natural skincare solutions. The market is also influenced by local special circumstances, such as the aging population in developed countries and the rising awareness about skincare in emerging markets. Underlying macroeconomic factors, such as disposable incomes and consumer spending patterns, further shape the market dynamics. Pharmacies play a crucial role in meeting the needs of customers by offering a wide range of skincare products and professional advice.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
